Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)

RenJi Hospital · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
immunotherapypancreatic-cancer
pancreatic cancer, first-line, metastatic pancreatic cancer, immunotherapy, angiogenesis inhibitors, anlotinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 905259
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.